证券之星消息，9月30日专用设备板块较上一交易日下跌0.23%，*ST新元领跌。当日上证指数报收于 3882.78，上涨0.52%。深证成指报收于13526.51，上涨0.35%。专用设备板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 603011 | 合殺書能 | 19.65 | 10.02% | 79.05万 | | 14.96 Z | | 002691 | 莫凯股份 | 8.81 | 9.99% | 21.99万 | | 1.93亿 | | 300813 | 泰林生物 | 36.52 | 8.21% | 5.62万 | | 2.02亿 | | 300836 | 佰奥智能 | 56.70 | 6.62% | 6.92万 | | 3.85亿 | | 002527 | 新时达 | 20.48 | 4.92% | 42.95万 | | 8.82亿 | | 002204 | 大连重工 | 6.41 | 4.74% | 128.54万 | | 8.25亿 | | ...

（文章来源：证券日报） 证券日报网讯 9月29日晚间，泰林生物发布公告称，全资子公司浙江泰林医疗器械有限公司于近期共取 得了1项计算机软件著作权登记证书，软件名称为"正电子药物分装控制软件V1.0"。 ...

关于取得计算机软件著作权登记证书的公告 证券代码：300813 证券简称：泰林生物 公告编号：2025-075 浙江泰林生物技术股份有限公司 浙江泰林生物技术股份有限公司董事会 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 2025 年 9 月 29 日 浙江泰林生物技术股份有限公司（以下简称"公司"）全资子公司浙江泰林 医疗器械有限公司（以下简称"泰林医疗器械"）于近期共取得了 1 项计算机软 件著作权登记证书，具体情况如下： | 序 | 软件名称 | 著作权 | 证书号 | 首次发表 | 登记日期 | 权利取 | 权利 | 登记号 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | | 人 | | 日期 | | 得方式 | 范围 | | | | 正电子药物 分装控制软 | 泰林医 | 软著登字第 | 2025/7/21 | 2025/9/19 | 原始取 | 全部 | 2025SR 182681 | | 1 | | 疗器械 | 16483014 号 | | | 得 | 权利 | ...

Core Viewpoint - Zhejiang Tailin Biotechnology Co., Ltd. has recently obtained five patent certificates, which will enhance its intellectual property protection and maintain its technological leadership in the industry [4]. Patent Acquisition Summary - The company’s wholly-owned subsidiary, Zhejiang Tailin Life Science Co., Ltd., has acquired five patents, including one invention patent. The details are as follows: - Patent for gas sterilization resistance detection device and method (Invention) [4] - Appearance patents for two types of plankton pretreatment equipment, a stationary sampler, and a compressed air microbiological testing instrument [4]. - The patents are expected to strengthen the company's innovation mechanism and core competitiveness, although they will not have a significant immediate impact on production and operations [4].

Group 1 - TaiLin Bio (SZ 300813) announced on September 22 that its wholly-owned subsidiary, Zhejiang TaiLin Life Sciences Co., Ltd., has recently obtained 5 patent certificates [1] - The patents include "Gas Sterilization Resistance Detection Device and Method for Zero Rise Period of Gas Concentration" and "Plankton Pretreatment Equipment (1)" [1] - For the fiscal year 2024, TaiLin Bio's revenue composition is projected to be 90.04% from the pharmaceutical industry and 9.96% from other businesses [1] Group 2 - As of the report, TaiLin Bio has a market capitalization of 4.5 billion yuan [1]

南财智讯9月22日电，泰林生物发布公告称，全资子公司泰林生命科学近日收到国家知识产权局颁发的5 项《专利证书》。专利名称分别为"气体浓度零上升期的气体灭菌抗力检测装置及其检测方法"、"浮游 生物预处理设备（1）"、"静置取样器"、"压缩空气微生物检验仪"和"浮游生物预处理设备（2）"。 ...

证券代码：300813 证券简称：泰林生物 公告编号：2025-074 浙江泰林生物技术股份有限公司 关于取得专利证书的公告 浙江泰林生物技术股份有限公司（以下简称"公司"）全资子公司浙江泰林 生命科学有限公司（以下简称"泰林生命科学"）于近期共取得了 5 项专利证书 （其中发明专利 1 项），具体情况如下： | 序号 | 专利名称 | 专利类型 | 申请号 | 授权公告日 | 专利权人 | | --- | --- | --- | --- | --- | --- | | 1 | 气体浓度零上升期的气体灭菌抗 力检测装置及其检测方法 | 发明 | 2023108605872 | 2025/9/12 | 泰林生命科学 | | 2 | 浮游生物预处理设备(1) | 外观 | 2024307565163 | 2025/9/12 | 泰林生命科学 | | 3 | 静置取样器 | 外观 | 2024307575339 | 2025/9/12 | 泰林生命科学 | | 4 | 压缩空气微生物检验仪 | 外观 | 2024307729182 | 2025/9/12 | 泰林生命科学 | | 5 | 浮游生物预处理设备(2) ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 301013 | 利和兴 | 29.23 | 19.99% | 90.83万 | | 25.79亿 | | 300521 | 爱司凯 | 32.30 | 16.56% | 29.95万 | | · 9.47 C | | 688400 | 凌云光 | 50.02 | 12.46% | 45.85万 | | 22.31亿 | | 688630 | 心碁微装 | 156.00 | 7.59% | 13.25万 | | 20.35亿 | | 300499 | 高潮股份 | 34.51 | 6.97% | 93.39万 | | 31.15亿 | | 301260 | 格力博 | 23.00 | 5.31% | 25.75万 | | 5.98亿 | | 002031 | 巨轮智能 | 9.51 | 5.08% | 603.29万 | | 58.22亿 | | 001400 | 江顺科技 | 81.24 | 4.13% | 4.55万 | | 3 ...

Group 1 - The stock of Tailin Bio (300813.SZ) has decreased by 5.33%, currently trading at 38.18 yuan, with a transaction volume of 150 million yuan and a market capitalization of 4.63 billion yuan [1] - The stock reached a high of 42.25 yuan yesterday, marking a new high for approximately 33 months since December 23, 2022 [1] - Tailin Bio announced that from August 8 to September 17, 2025, its controlling shareholder and actual controller's concerted action party, Gao De Investment, will reduce its holdings by a total of 1.18177 million shares, accounting for 0.98% of the company's total share capital [1] Group 2 - Following this equity change, the shareholding ratio of the company's controlling shareholder, actual controller, and their concerted action parties will decrease from 58.91% to 57.94% [1]

本次权益变动后，公司控股股东、实际控制人及其一致行动人持股比例由58.91%下降至 57.94%。 9月17日，泰林生物(300813.SZ)发布公告称，2025年8月8日至2025年9月17日，公司控股股 东、实际控制人的一致行动人高得投资通过集中竞价方式合计减持118.177万股，占公司总股本比 例的0.98%。 ...